EVLV

Over the past six months, EVLV stock has declined by -6.07% weekly, -11.76% monthly, and -38.63% over the last year, reaching a new 52-week low of $4.82 on September 22, 2026. In Q4 2025, Evolv reported an adjusted EPS of -$0.03 on $38.5 million revenue, beating estimates. For Q2 2026, the company beat estimates with $43.8 million revenue and a narrower loss of $0.02 per share, subsequently raising its full-year 2026 revenue guidance to between $180 million and $185 million, with expected adjusted EBITDA of $15 million to $16 million and positive cash flow. Analysts generally maintain a 'Strong Buy' rating with a consensus target price of $9.85, indicating a potential 100.61% upside, and an insider purchased 19,100 shares at approximately $4.96 each.